80 related articles for article (PubMed ID: 1585220)
1. Splenectomy in the chronic myeloproliferative syndromes. A retrospective risk-versus-benefit analysis.
Jacobs P; Wood L; Dent DM
S Afr Med J; 1992 May; 81(10):499-503. PubMed ID: 1585220
[TBL] [Abstract][Full Text] [Related]
2. Risk factors associated with mortality and morbidity after elective splenectomy.
Aksnes J; Abdelnoor M; Mathisen O
Eur J Surg; 1995 Apr; 161(4):253-8. PubMed ID: 7612767
[TBL] [Abstract][Full Text] [Related]
3. Massive splenomegaly.
Johnson HA; Deterling RA
Surg Gynecol Obstet; 1989 Feb; 168(2):131-7. PubMed ID: 2911790
[TBL] [Abstract][Full Text] [Related]
4. Splenectomy for the massively enlarged spleen.
Danforth DN; Fraker DL
Am Surg; 1991 Feb; 57(2):108-13. PubMed ID: 1992865
[TBL] [Abstract][Full Text] [Related]
5. Perioperative complications of splenectomy for hematologic disease.
MacRae HM; Yakimets WW; Reynolds T
Can J Surg; 1992 Aug; 35(4):432-6. PubMed ID: 1498746
[TBL] [Abstract][Full Text] [Related]
6. Outcomes following splenectomy in patients with myeloid neoplasms.
Rialon KL; Speicher PJ; Ceppa EP; Rendell VR; Vaslef SN; Beaven A; Tyler DS; Blazer DG
J Surg Oncol; 2015 Mar; 111(4):389-95. PubMed ID: 25488568
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic splenectomy in patients with fever of unknown origin and splenomegaly.
Han B; Yang Z; Yang T; Gao W; Sang X; Zhao Y; Shen T
Acta Haematol; 2008; 119(2):83-8. PubMed ID: 18305380
[TBL] [Abstract][Full Text] [Related]
8. Splenectomy for massive splenomegaly: long-term results and risks for mortality.
Taner T; Nagorney DM; Tefferi A; Habermann TM; Harmsen WS; Slettedahl SW; Donohue JH
Ann Surg; 2013 Dec; 258(6):1034-9. PubMed ID: 23222031
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significant of splenectomy for fever of unknown origin with splenomegaly].
Yang ZY; Han B; Yang T; Gao WS; Sang XT; Duan MH; Zhao YQ; Shen T
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3385-8. PubMed ID: 17313846
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis against hepatitis B virus recurrence after liver transplantation for hepatitis B virus-related end-stage liver diseases with severe hypersplenism and splenomegaly: role of splenectomy.
Zhang Y; Yan L; Wen T; Li B; Zhao J; Chen Z; Wang W; Xu M; Yang J; Wei Y; Ma Y; Jiang L
J Surg Res; 2012 Nov; 178(1):478-86. PubMed ID: 22483806
[TBL] [Abstract][Full Text] [Related]
11. Splenectomy for haematological diseases--a single institution experience.
Mittelman M; Kyzer S; Zeidman A; Bendayan D; Ramadan E; Cohen A; Cahimoff C
Haematologia (Budap); 1997; 28(4):185-98. PubMed ID: 9408762
[TBL] [Abstract][Full Text] [Related]
12. [Splenectomy in haematologic diseases. Clinical indications and surgical technique].
Pugliese R; Maggioni D; Scandroglio I; Sansonna F; Grilloa G; Di Lernia S; Ferrari GC; Boniardi M; Costanzi A; Magistro C
Chir Ital; 2005; 57(3):283-91. PubMed ID: 16231815
[TBL] [Abstract][Full Text] [Related]
13. Indications for and efficacy of splenectomy for haematological disorders.
Bickenbach KA; Gonen M; Labow DM; Strong V; Heaney ML; Zelenetz AD; Coit DG
Br J Surg; 2013 May; 100(6):794-800. PubMed ID: 23436638
[TBL] [Abstract][Full Text] [Related]
14. Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation.
Santos FP; Tam CS; Kantarjian H; Cortes J; Thomas D; Pollock R; Verstovsek S
Leuk Lymphoma; 2014 Jan; 55(1):121-7. PubMed ID: 23573823
[TBL] [Abstract][Full Text] [Related]
15. Splenectomy in patients with mixed myelodysplastic/myeloproliferative disease.
Kraemer D; Rüdiger T; Reimer P; Müller-Hermelink HK; Wilhelm M
Ann Hematol; 2002 Jun; 81(6):308-11. PubMed ID: 12107559
[TBL] [Abstract][Full Text] [Related]
16. Splenectomy in haematology--a 5-year single centre experience.
Wood L; Baker PM; Martindale A; Jacobs P
Hematology; 2005 Dec; 10(6):505-9. PubMed ID: 16321816
[TBL] [Abstract][Full Text] [Related]
17. Trends in laparoscopic splenectomy for massive splenomegaly.
Grahn SW; Alvarez J; Kirkwood K
Arch Surg; 2006 Aug; 141(8):755-61; discussion 761-2. PubMed ID: 16924082
[TBL] [Abstract][Full Text] [Related]
18. [Early postoperative complications in elective splenectomy in hematologic diseases].
Stevović D; Dugalić D; Pesko P; Petrović M; Zuvela M; Kovacević P
Acta Chir Iugosl; 1989; 36(2):257-67. PubMed ID: 2485571
[TBL] [Abstract][Full Text] [Related]
19. Splenectomy for haematological disorders: a single center study in 150 patients from Oman.
Machado NO; Grant CS; Alkindi S; Daar S; Al-Kindy N; Al Lamki Z; Ganguly SS
Int J Surg; 2009 Oct; 7(5):476-81. PubMed ID: 19695352
[TBL] [Abstract][Full Text] [Related]
20. Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic.
Mesa RA; Nagorney DS; Schwager S; Allred J; Tefferi A
Cancer; 2006 Jul; 107(2):361-70. PubMed ID: 16770787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
